Efficacy and safety of olezarsen in lowering apolipoprotein C-III and triglycerides in healthy Japanese Americans

Abstract Background Olezarsen is a GalNAc3-conjugated, hepatic-targeted antisense oligonucleotide that lowers apolipoprotein C-III (apoC-III) and triglyceride levels. The efficacy and safety of olezarsen has not previously been studied in ethnically diverse American populations. The aim of this stud...

Descrición completa

Detalles Bibliográficos

Principais autores:	Ewa Karwatowska-Prokopczuk, Anastasia Lesogor, Jing-He Yan, Angelika Hoenlinger, Alison Margolskee, Lu Li, Sotirios Tsimikas
Formato:	Artigo
Idioma:	Inglês
Publicado:	BMC 2024-10-01
Series:	Lipids in Health and Disease
Assuntos:	Triglycerides ApoC-III Ethnicity Antisense oligonucleotide Pancreatitis Cardiovascular disease
Acceso en liña:	https://doi.org/10.1186/s12944-024-02297-5
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!